I certainly understand people's frustrations, I to

I certainly understand people's frustrations, I too was looking for a home run sooner. I do however believe that we need to look at it like any biotech that's dealved into some new technology. Concept to drug approval often takes well over a decade to achieve.

I've mentioned IMGN before, it's many decades since I first read about the technology. Much has been learned over those decades, and the drugs keep improving, but only one partner has achieved an approval using their technology, and their wholly owned drug is looking good in Phase 3, but still over a year from anticipated approval. For those who listened to me last year or the year before when the stock was $2, they've got a healthy gain, but I still believe the company has the potential to be as big as SGEN, at least 5 times what it is today, so I certainly believe it's got a long way to go.

If you knew nothing about OWCP before, but read about a biotech company dealing in cannabis that had multiple filed patents, I suspect that many would be willing to invest at prices substantially higher than it is today. The problem is, we do know the history. We know Zev spoke of products on market shelves over a year ago. We know of language in their PR's that didn't make it clear when they'd consider marketing product. Even now, we don't know that they'd market a product on clearly seeing efficacy, or only after it has approval as a drug by some authority. While I believe it's their current intent to market on proven efficacy, but without drug approval, all that could change if they partnered with a company that only wanted to market approved drugs. The good news in such a scenario is that such a partnership would give a tremendous boost to the stock price as it should come with major funding.

The company is evolving, we have a choice of accepting the direction they're taking, or bailing out and taking our losses. I do not intend to bail out.

Gary